Health, Wealth, and the 21st Century Cures Act
Name
Health-Wealth-and-21st-century.pdf
Size
108.72 KB
Format
Adobe PDF
Checksum (MD5)
d9226082d661fa5799dd9138dc0c6533
Author(s) • •
Philipson, Tomas J.
von Eschenbach, Andrew C.
Lo, Andrew W
Date Issued
October 2015
Journal
JAMA Oncology
Citation
Lo, Andrew W.; Philipson, Tomas J. and von Eschenbach, Andrew C. “Health, Wealth, and the 21st Century Cures Act.” JAMA Oncology 2, no. 1 (January 2016): 17.
Version
Author's final manuscript
Abstract
Americans are increasingly apprehensive about our future, so it is inspiring when Congress produces legislation intended to both enhance our health and expand our economy. The 21st Century Cures Act,1 recently passed by the House with an impressive bipartisan majority vote of 344 to 77, intends to accelerate the many-step process of drug discovery and development, from basic scientific research to clinical development to delivery, distribution, and ongoing monitoring. Among other things, the legislation boosts National Institute of Health funding, dramatically speeds up the US Food and Drug Administration (FDA) approval process, and aims to make use of new information technology to better monitor the performance of medical products after they reach the market. This landmark bill now awaits a comparable piece of legislation being developed by the Senate Health Education, Labor, and Pensions Committee. Together, they will transform the biomedical ecosystem and provide the foundation for the next several decades of innovative life-saving and health-enhancing solutions for our nation and the world.
MIT Department
Sloan School of Management
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1001/jamaoncol.2015.4221